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A B S T R A C T
We analyzed the effect of the combination of citral, eugenol and thymol, respectively 
the main constituents of essential oils of Cympobogon citratus (DC) Stapf, Poaceae (lemon 
grass), Syzygium aromaticum (L.) Merr. & L.M. Perry, Myrtaceae (clove) and Thymus vulgaris 
L., Lamiaceae (thyme), on the proliferation of the trypanosomatids Crithidia fasciculata 
and Trypanosoma cruzi. The constituents were initially added individually at different 
concentrations to C. fasciculata cultures to estimate the IC50/24h. Concentrations in 
a triple combination were about 2 times and 16.5 times lower against C. fasciculata and 
T. cruzi, respectively, as compared to isolated compounds. Incubation of C. fasciculata with 
the trypanocydal agent benznidazole did not affect parasite growth at concentrations up 
to 500 μg/ml, but the IC50 of this drug against T. cruzi was 15.8 μg/ml, a value about 2-5 
times higher than that of constituents in the triple combination. Analysis of treated C. 
fasciculata by scanning electron microscopy showed rounding of the cell body. Our data 
show that combination of essential oil constituents resulted in increased inhibitory activity 
on growth of both non-pathogenic and pathogenic trypanosomatid species and indicate 
that the non-patogenic C. fasciculata may represent a resistant model for drug screening in 
trypanosomatids.
© 2013 Elsevier Editora Ltda. 
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Introduction
Protozoa of the Trypanosomatidae family (Euglenozoa, 
Kinetoplastea) belong to a cosmopolitan group of flagellates, 
some of which are important parasites of medical, veterinary 
and agricultural interest. Several members of this family 
are causal agents of severe diseases in humans (such as 
Trypanosoma cruzi, which causes Chagas disease in the 
Americas, and Leishmania spp. which causes leishmaniasis 
in the world), animals and plants. This family includes 
monoxenic trypanosomatids, such as those belonging to 
the genera Crithidia and Herpetomonas, which commonly are 
insect parasites (Maslov et al., 2013; McGhee and Cosgrove, 
1980; Podlipaev, 2000; Wallace, 1966), although there are some 
reports on the isolation of such “lower trypanosomatids” from 
immunodeficient human hosts (Chicharro and Alvar, 2003; 
Morio et al., 2008).
Many insect trypanosomatids, such as Crithidia fasciculata, 
are routinely used as well accepted models for biochemical, 
cell biology and molecular studies regarding biological aspects 
of the Trypanosomatidae family. They are easily maintained 
in axenic cultures and contain metabolic pathways and 
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homologues to virulence factors similar to those found in 
pathogenic trypanosomatids, such as Leishmania spp. and 
Trypanosoma cruzi (Comini et al., 2005; Grazu et al., 2012; 
Russell et al., 1984; Santos et al., 2006; Tasanor et al., 2006; 
Ueda-Nakamura et al., 2006). Due to their physiological 
similarities with the pathogenic species, the use of non-
pathogenic trypanosomatids appears as a model of choice 
for the screening and evaluation of new trypanocidal 
compounds. 
For the treatment of Chagas disease the most commonly 
used drug is benznidazole, a nitroimidazole derivative 
developed in the early 1960s, active in the acute stage of 
disease, but ineffective in the chronic stage (Santos et al., 
2008; Urbina, 2010). This treatment can be highly toxic with a 
variety of side effects. The difficulties found in the treatment 
of Chagas disease, along with the increasing resistance of T. 
cruzi to treatment (Coura, 2007; Santos et al., 2008; Teixeira et 
al., 2006; Urbina, 2010) indicate the need to search new drugs. 
Greater attention is being given to extracts and biologically 
active compounds isolated from plants commonly used in folk 
medicine for the potential development of herbal medicines 
that could be used as trypanocidal agents. 
Essential oils (EO) are complex mixtures of secondary 
metabolites isolated from various plants. These mixtures are 
known for their bactericidal, virucidal and fungicidal effects, 
and are widely used for embalming and for food preservation. 
The action of essential oils is probably related to their natural 
protective role in plants (Bakkali et al., 2008). It has been 
recently shown that several EO, or their constituents, have 
inhibitory activity against trypanosomatid protozoa (Alviano 
et al., 2012; Cardoso and Soares, 2010; de Medeiros et al., 2011; 
Dos Santos et al., 2012; Habila et al., 2010; Misra et al., 2009; 
Oliveira et al., 2009; Santoro et al., 2007a; 2007b; 2007c; Teixeira 
et al., 2006; Ueda-Nakamura et al., 2006).
It has been shown that EO of clove [Syzygium aromaticum 
(L.) Merr. & L.M. Perry, Myrtaceae], thyme [Thymus vulgaris 
(L.), Lamiaceae] and lemon grass [Cympobogon citratus (DC) 
Stapf., Poaceae] and their main constituents (eugenol, thymol 
and citral, respectively) inhibit the  growth of Trypanosoma 
cruzi (Santoro et al., 2007a; 2007b; 2007c) and Leishmania spp. 
(Oliveira et al., 2009; Santin et al., 2009). However, in these 
works EO and their main constituents were tested individually. 
There are still no data showing that combination of these 
constituents may result in a synergistic/addictive action on 
trypanosomatids, increasing the microbicidal activity of these 
molecules. Therefore, in this study we analyzed the effect 
of the combination of eugenol, thymol and citral on non-
pathogenic (Crithidia fasciculata) and pathogenic (Trypanosoma 
cruzi) trypanosomatids.
Materials and methods
Parasites
Crithidia fasciculata and Trypanosoma cruzi cultures were 
maintained at 28°C in LIT (liver infusion-tryptose) medium 
containing 10% fetal bovine serum, and culture passaging 
every 24 or 72 h, respectively. Three-day-old T. cruzi culture 
epimastigotes were used for the experiments. C. fasciculata 
stock cultures were stored at 4°C for two weeks maximum 
and 24 h old cultures (choanomastigote forms) from recent 
passages were used for the experiments.
Essential oil constituents
Citral, eugenol and thymol were purchased from Sigma 
(Sigma Chem. Co., St Louis, MO, USA). They are the main 
constituents of the essential oils of lemon grass (Cymbopogon 
citratus), clove (Syzygium aromaticum) and thyme (Thymus 
vulgaris), respectively. The compounds were diluted in 
dimethylsulfoxide (DMSO) at an initial concentration of 100 
mg/ml (first stock). For use, this first stock was further diluted 
at 1:100 in LIT medium, thus resulting in a second stock 
solution at a concentration of 1 mg/ml in culture medium. By 
this procedure, DMSO was diluted to 1% in the second stock, 
thus ensuring that when used its final concentration never 
exceeded 0.5%, a concentration that is not harmful for the 
parasites. Stocks were stored at 4°C in the dark to prevent 
degradation (Guimarães et al., 2008). The second stock, used 
for all experiments, was freshly prepared before use.
Effect of citral, thymol and eugenol on parasite growth
Crithidia fasciculata parasites were added to 1 ml of LIT medium 
in 24-well plates at a concentration of 1 × 106 cells/ml and then 
the isolated constituents were added to the wells at different 
concentrations (20, 50, 100, 200, 300, 400 or 500 μg/ml) in order 
to estimate the IC50/24 h (growth inhibition by 50% after 24 
h of treatment) and the IC90/24 h (growth inhibition by 90%) 
of isolated compounds. The plates were kept at 28°C and cell 
counts were performed after 24 h using Neubauer chamber 
to evaluate the number of living parasites, compared to the 
growth of untreated control cultures. As a control, untreated 
parasites were grown in LIT medium containing either 0.5% 
DMSO or different concentrations (20, 50, 100, 200, 300, 400 or 
500 μg/ml) of benznidazole (stock solution: 1 mg/ml in DMSO). 
All experiments were performed in triplicate.
After determining the IC50/24 h and IC90/24 h of each 
component individually, experiments were performed with 
Crithidia fasciculata by using combinations (citral+eugenol, 
citral+thymol, eugenol+thymol, citral+eugenol+thymol) 
of the IC50/24 h values in LIT medium, to assess possible 
synergistic/additive effects. Cell counts were then performed 
after 24 h of incubation using a Neubauer chamber. The 
data obtained allowed to calculate the percentage of growth 
inhibition obtained with the different combinations. The triple 
combination was then further tested at different dilutions (2, 
3 and c.) on T. cruzi.
Isobologram analysis was performed using CompuSyn 
software. Results were interpreted using the Combination 
Index (CI), a quantitative measure of the degree of drug 
interaction in terms of synergism and antagonism for a 
given endpoint of the effect measurement (Chou and Talalay, 
1981), and the Dose Reduction Index (DRI), a measure of fold 
reduction of the dose of each drug in a synergistic combination 
at a given effect level when compared with the doses of each 
drug alone. All experiments were performed in triplicate.
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Microscopy
C. fasciculata parasites incubated for 24 h with the IC50/24 h 
or IC90/24 h values of the triple combination (citral/eugenol/
thymol) were washed in PBS (pH 7.2) and digital images of 
treated cells were obtained using a Nikon Eclipse E600 light 
microscope, equipped with differential interference contrast 
(DIC) objectives.
For scanning electron microscopy (SEM), cells treated for 
24 h with the IC50/24 h or IC90/24 h of the triple combination 
were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer 
(pH 7.2) and then adhered to glass coverslips pre-coated with 
0.1% poly-L-lysine. The samples were fixed with 1% osmium 
tetroxide in 0.1 M cacodylate buffer (pH 7.2) for 15 min, 
dehydrated in increasing concentrations of acetone (50, 70, 90 
and 100%), critical-point dried, mounted on a SEM stub and 
coated with a 20 nm-thick gold layer. Analysis was performed 
using a Jeol JSM 6360 scanning electron microscope.
Cytotoxicity
L-929 fibroblasts were cultivated in a 24-wells plate containing 
1 ml DMEM (Dulbecco’s Modified Eagle`s Medium; Sigma)/10% 
fetal bovine serum/1% L-glutamine per well. Each well had 
a round coverslip at the bottom. The plate was incubated at 
37°C and 5% CO2, culture medium was replaced for a new one 
containing different concentrations (IC50, ½ IC50, ¼ IC50 or IC90) 
of the triple combination after 24 h. After incubation for 24 h 
at 37°C and 5% CO2, the medium was removed, the coverslips 
were washed in PBS buffer (pH 7.2) and cell viability was then 
calculated after staining with the vital dye Trypan Blue. As a 
control, cells were grown in medium lacking the constituents. 
The experiment was performed in triplicate.
Results
A control growth curve showed that C. fasciculata axenic 
cultures reach the exponential phase of growth soon after 24 
h, with a stationary phase after 48 h. A similar growth curve 
was obtained when the cells were cultivated in LIT medium 
containing 1% DMSO (data not shown), thus demonstrating 
that this diluent at maximal concentration did not affect 
cell growth and therefore could not influence the effect of 
the essential oil constituents on the parasites. Therefore, all 
experiments were performed with maximal concentration 
of 0.5% DMSO.
Firstly we established the IC50/24 h and IC90/24 h values for 
the isolated constituents on Crithidia fasciculata (Fig. 1a). The 
best results were obtained using thymol, followed by citral 
and eugenol (Table 1). To evaluate a possible synergistic/
additive effect with the constituents, thus allowing reduction 
in concentrations needed to inhibit cell growth, the IC50/24 h 
values of each constituent were used as a pair combination 
or as three-constituent combination. The data obtained 
showed that combinations increased the inhibitory effect 
up to 90%, with reduction in the drug concentration in the 
triple combination to nearly half of that needed when the 
components were used individually (Table 1). 
Fig. 1 - Effect of essential oil constituents on trypanosomatids 
and fibroblasts. A, Effect of thymol (triangle), citral (square) and 
eugenol (diamond) on Crithidia fasciculata growth in LIT medium. 
B, Effect of different dilutions of the triple combination (from 
Crithidia fasciculata IC50/24 h values, see below) on Trypanosoma 
cruzi growth in LIT medium. C, Cytotoxicity of different 
concentrations of the triple combination (Crithidia fasciculata 
IC50/24 h values) on L-929 fibroblasts in vitro. Final concentration 
of the triple combination in LIT medium: IC50 48 μg/ml eugenol, 
39 μg/ml citral, 17 μg/ml thymol; IC50/2 24 μg/ml eugenol, 19.5 
μg/ml citral, 8.5 μg/ml thymol; IC50/4 12 μg/ml eugenol, 9.75 μg/
ml citral, 4.25 μg/ml thymol; IC50/8 6 μg/ml eugenol, 4.8 μg/ml 
citral, 2.13 μg/ml thymol.
Constituent
Crithidia fasciculata Trypanosoma cruzi
IC50/24 h IC90/24 h IC50/24 h
Citral 76.3 μg/ml
(501.18 μM)
146.0 μg/ml
(959.01 μM)
42 μg/ml
(275.88 μM)a
Eugenol 93.7 μg/ml 
(570.61 μM)
300 μg/ml
(1826.93 μM)
246 μg/ml
(1498.08 μM)b
Thymol 32.5 μg/ml 
(216.35 μM)
62.5 μg/ml
(416.05 μM)
62 μg/ml
(412.73 μM)c
Triple Combination:
Citral
39.1 μg/ml 
(256.83 μM)
68 μg/ml
(446.66 μM)
7.92 μg/ml
(52.02 μM)
Triple Combination: 
Eugenol
48.1 μg/ml 
(292.92 μM)
140 μg/ml 
(852.57 μM)
9.75 μg/m 
(59.37 μM)
Triple Combination: 
Thymol
16.6 μg/ml  
(110.5 μM)
29 μg/ml 
(193.05μM)
3.45 μg/ml 
(22.97 μM)
Benznidazol > 500 μg/ml 
(1.92 mM)
> 500 μg/ml 
(1.92 mM)
15.8 μg/ml
aSantoro et al., 2007a. 
bSantoro et al., 2007b. 
cSantoro et al., 2007c.
Table 1 
Concentrations of citral, eugenol and thymol needed to 
inhibit C. fasciculata and Trypanosoma cruzi culture growth 
in 50% or 90% after 24 h of cultivation in LIT medium 
(IC50/24 h and IC90/24 h, respectively).
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Composition Concentration Combination Index 
(CI)
citral+eugenol 76:94 0.96296 
citral+thymol 76:33 1.15518
eugenol+thymol 94:33 1.16439
thymol+citral+eugenol 33:76:94 0.99372
Dose Total Dose (μg/ml) Fa CI Value
IC50 103.774 0.7657 0.86497
IC50/2 52.02 0.7157 0.47792
IC50/4
26.01 0.7166 0.23856
Recalculated IC50
21.114 0.5 0.27499
IC50/8
13.0356 0.1666 0.31770
IC50 48 μg/ml eugenol, 39 μg/ml citral, 17 μg/ml thymol; IC50/2 24 
μg/ml eugenol, 19.5 μg/ml citral, 8.5 μg/ml thymol; IC50/4 12 μg/
ml eugenol, 9.75 μg/ml citral, 4.25 μg/ml thymol; IC50/8 6 μg/ml 
eugenol, 4.8 μg/ml citral, 2.13 μg/ml thymol; Recalculated IC50 7.92 
μg/ml citral, 9.75 μg/ml eugenol, 3.45 μg/ml thymol.
Table 2 
Composition, concentration (μg/ml in LIT medium) 
and combination index (CI) of essential oil constituents 
evaluated on Crithidia fasciculata. 
Table 3 
Dose, effect level (Fa) and combination index (CI) used for 
Trypanosoma cruzi isobologram.
The isobologram analysis showed that the increased 
inhibitory activity observed in C. fasciculata with the citral/
eugenol combination and with the triple combination was due 
to synergy (CI < 1). However, the calculated CI for these mixtures 
was close to 1 and thus could represent an additive effect (Fig. 2; 
Table 2). The citral/thymol and eugenol/thymol combinations had 
CI > 1, indicating an antagonist relationship. And concentrations 
of benznidazole as high as 500 μg/ml (1.92 mM) did not affect 
C. fasciculata growth. 
To test whether C. fasciculata could represent a model to study 
the effect of drugs against pathogenic trypanosomatids, different 
dilutions of the triple combined C. fasciculata IC50/24 h value 
(IC50, IC50/2, IC50/4, IC50/8) were then applied to Trypanosoma cruzi 
cultured epimastigotes. Dilutions up to IC50/4 resulted in about 75% 
growth inhibition. A 1/6 dilution of the triple C. fasciculata IC50/24 
h combination was able to inhibit T. cruzi epimastigote growth in 
about 50% (Fig 1b). The resulting recalculated IC50/24 h for citral, 
eugenol and thymol were 7.92, 9.75 and 3.45 μg/ml, respectively 
(Table 1). Thus, the individual values for each constituent in the 
triple IC50 combination were about 2-5 times lower (Table 1) than 
that obtained with benznidazol for T. cruzi (15.8 μg/ml). 
Isobologram analysis showed that when applied to T. 
cruzi all dilutions of the triple combination resulted in CI < 1 
Fig. 2 - Synergy, antagonism and additive effect analysis 
(isobologram) with Crithidia fasciculata. Fa: Effect level; CI: 
Combination Index. CI < 1: Synergy; CI 1: Additive effect;  
CI > 1: Antagonism.
Fig. 3 - Synergy, antagonism and additive effect analysis 
(isobologram) on Trypanosoma cruzi. Fa, Effect level; CI, 
Combination Index. CI < 1, Synergy; CI 1, Additive effect; CI > 1, 
Antagonism. Final concentration in LIT medium, IC50 48 μg/ml 
eugenol, 39 μg/ml citral, 17 μg/ml thymol; IC50/2, 24 μg/ml 
eugenol, 19.5 μg/ml citral, 8.5 μg/ml thymol; IC50/4, 12 μg/ml  
eugenol, 9.75 μg/ml citral, 4.25 μg/ml thymol; IC50/8, 6 μg/
ml eugenol, 4.8 μg/ml citral, 2.13 μg/ml thymol; Recalculated 
IC50, 7.92 μg/ml citral, 9.75 μg/ml eugenol, 3.45 μg/ml thymol.
(Fig 3; Table 3). According to the Dose Reduction Index (DRI), 
the concentrations of citral, eugenol and thymol could be 
reduced 5.75, 26.2 and 15.9 times, respectively, to achieve a Fa 
(effect level) = 0.5 (50%). Applying these theoretical dilutions to 
the IC50 values of respectively 42, 246 and 62 μg/ml for citral, 
eugenol and thymol (previously published: see Table 1), the 
recalculated IC50/24 h values for T. cruzi are 7.3, 9.59 and 3.9 
μg/ml, respectively. These values are nearly identical as those 
obtained experimentally (see above).
However, fibroblasts incubated for 24 h with the triple 
combination IC50/24 h or IC90/24 h values did not survive the 
treatment: incubation with the ½ IC50 value induced death of 
more than 60% of the cells. A non-toxic dose (less than 8% cell 
death) was obtained only with the ¼ IC50/24 h values (Fig 1c).
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sp. to standard trypanosomatid agents (Bacchi et al., 1974). Our 
data shows that C. fasciculata is highly tolerant to benznidazole 
(used in Chagas disease treatment), since concentrations as 
high as 500 μg/ml (1.92 mM) did not affect cell growth. The 
insect trypanosomatid Herpetomonas samuelpessoai is also 
resistant to benznidazole at concentrations up to 3.84 mM 
(Holetz et al., 2003). These data indicate that, at least for this 
reference drug, monoxenic trypanosomatids are more resistant 
than T. cruzi and indicate that the non-patogenic C. fasciculata 
may represent a resistant cell model for drug screening in 
trypanosomatids.
Different EO components can interact to either reduce or 
increase antimicrobial efficacy, thus producing four possible 
effects: 1) Additive, when the combined effect is equal to the 
sum of individual effects; 2) Antagonis, when the effect of one 
or both compounds is less when they are applied together 
than when individually applied; 3) Synergism, when the 
effect of combined substances is greater than the sum of the 
individual effects; and 4) Indifference, defined as absence of 
interactions (Bassole and Juliani, 2012). In this work we have 
tested for the first time a combination of EO constituents 
against trypanosomatid protozoa, aiming to observe a 
possible synergistic/additive effect. Isobologram analysis of 
the combination of citral, eugenol and thymol showed that on 
C. fasciculata most combinations had an antagonistic/additive 
effect (CI ≥ 1). However, when different dilutions of the triple 
combination were applied to T. cruzi a synergistic effect (CI < 
1) was observed at all dilutions tested, thus indicating that T. 
cruzi is much more susceptible than C. fasciculata.  
The data obtained so far with pathogenic trypanosomatids 
indicate a higher sensitivity of these parasites to treatment 
with individual EO components, as compared to the total oil 
(Oliveira et al., 2009; Santin et al., 2009; Santoro et al., 2007a; 
2007c). Our data indicate that they are also more susceptible to 
the individual constituents and to the combination than non-
pathogenic C. fasciculata, at least to the constituents evaluated 
in this work. Therefore, it is possible that combination of 
different EO constituents could be more efficient when applied 
to pathogenic species such as T. cruzi and Leishmania spp., 
thus appearing as an important tool in the search for new 
effective drugs. Also, the use of C. fasciculata as a model for 
study to investigate drug effects may be considered for future 
experimental designs. 
Analysis by scanning electron microscopy (SEM) showed 
no significant morphological differences after the diverse 
treatments with C. fasciculata, occurring only an increased 
rounding in cells treated with IC90/24 h concentrations, 
when compared to cells treated with the IC50/24 h value, and 
these compared to the control. Previous studies on other 
trypanosomatids also demonstrated cell rounding (Santoro 
et al., 2007a; 2007b), besides formation of membrane blebs 
(Santoro et al., 2007c) or multiseptated cells (Oliveira et 
al., 2009). Citral incubated Leishmania amazonensis showed 
agglomeration of cells, rounded appearance, rupture of plasma 
membrane and changes in the flagellar membrane (Santin et 
al., 2009). The changes in cell morphology can be explained by 
the properties of the EO constituents. As typically lipophylic 
molecules, they cross the cell membrane and disrupt the 
phospholipid layer structure. Cytotoxicity appears to include 
Fig. 4 - Scanning electron microscopy of C. fasciculata cells 
treated for 24 h with the triple IC50 or IC90 combination. a) 
control; b) detail of a control cell; c) cell incubated with the 
IC50; d) cell Incubated with the IC90. Bars, a = 10 μm; b,c,d 
= 2 μm; Insets, light microscopy images by Differential 
Interference Contrast (DIC) microscopy; Bar, 10 μm.
After treatment with the triple IC50/24 h or IC90/24 h 
the C. fasciculata  parasites presented rounding of the cell 
body, acquiring a pear-like shape (Fig. 4c, d), in contrast to 
the elongated body of control cells (Fig. 4a, b). There were 
no significant morphological differences when comparing 
treatments with components alone or in combination, except 
for a more drastic effect for the survivors from the IC90/24 
treatment, which presented a more rounded/flattened cell 
body than those cells treated with the IC50/24 h concentration.
Discussion
Crithidia fasciculata is an insect trypanosomatid that can 
be useful as a cell biology model for drug screening with 
potential effect on the pathogenic relatives Leishmania spp. 
and Trypanosoma cruzi, the causative agents of Leishmaniasis 
and Chagas disease, respectively (Tasanor et al., 2006). The 
difficulties found in treatment of both diseases, together with 
the increasing parasite resistance to treatment (Coura, 2007; 
Santos et al., 2008; Teixeira et al., 2006)  carry the need to 
search for new drugs. In this sense, the use of non-pathogenic 
trypanosomatids appears as a model of choice for the screening 
and evaluation of new compounds, due to their physiological 
similarities with the pathogenic species.
Plants represent an important source of potential new 
drugs, with several reports demonstrating the biological 
activities of essential oils (EO), or their major constituents, on 
pathogenic (Alviano et al., 2012)  or non-pathogenic (Holetz et 
al., 2003; Pedroso et al., 2006) trypanosomatids. In this work we 
have tested the inhibitory effects of a combination of the EO 
constituents eugenol, thymol and citral on the trypanosomatid 
C. fasciculata. When tested separately, the inhibitory effect on 
culture growth was similar to that observed in previous studies 
using essential oils/constituents against the trypanosomatids 
Crithidia deanei (Pedroso et al., 2006), Herpetomonas samuelpessoai 
(Holetz et al., 2003), Leishmania amazonensis (Ueda-Nakamura 
et al., 2006), Leishmania chagasi (Oliveira et al., 2009) and 
Trypanosoma cruzi (Santoro et al., 2007a; 2007b; 2007c). It has 
been shown that C. fasciculata is more resistant than Leptomonas 
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such membrane damage, which can lead to the leakage of 
macromolecules and to lysis. Furthermore, cytotoxicity may 
be related to depolarization of the mitochondrial membranes 
by decreasing the membrane potential, besides action in 
the cytoplasm and nucleus (Bakkali et al., 2008). Our data 
demonstrate that combining EO constituents increase their 
inhibitory activity on trypanosomatids, allowing synergistic 
interactions between them. Thus, the combination of the 
components activities on different specific cell pathways may 
also induce high cytotoxicity. 
We found a high cytotoxic effect when treating fibroblasts 
with optimal concentrations that inhibited C. fasciculata growth. 
Previous studies also showed citral toxicity to mammalian cells 
at concentrations only 2-14 times higher than that considered 
toxic to L. amazonensis and T. cruzi (Santin et al., 2009; Santoro 
et al., 2007a; 2007c). Further studies using combinations of 
other essential oil constituents may indicate new combinations 
with lower toxicity to the mammalian cell.
Our data point the need for further studies that could 
optimize the synergistic effect of the combination of EO 
constituents, thus allowing the use of lower concentrations of 
each component in the combination. Finally, the use of non-
pathogenic trypanosomatids such as Crithidia fasciculata for the 
screening of new trypanocidal drugs can be effective, since a 
drug that is active on this parasite may be even more active 
on Trypanosoma cruzi or Leishmania spp.
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